Antitumor activity of the HER2 dimerization inhibitor pertuzumab on human colon cancer cells in vitro and in vivo

By Pohl Michael   Stricker I.   Schoeneck A.   Schulmann K.   Klein-Scory S.   Schwarte-Waldhoff I.   Hasmann M.   Tannapfel A.   Schmiegel W.   Reinacher-Schick A.  

Journal of Cancer Research and Clinical Oncology, Vol. 135, Iss. 10, 2009-10 ,pp. : 1377-1386

Springer Publishing Company

Access to resources Recommend Favorite

A Caspase-6 and Anti-HER2 Antibody Chimeric Tumor-Targeted Proapoptotic Molecule Decreased Metastasis of Human Osteosarcoma

By Wang Li-Feng   Zhou Yong   Xu Yan-Ming   Qiu Xiu-Chun   Zhou Ben-Gen   Wang Fang   Long Hua   Chen Xiang   Yang Tong-Tao   Ma Bao-An   Fan Qing-Yu   Yang An-Gang  

Cancer Investigation, Vol. 27, Iss. 7, 2009-08 ,pp. : 774-780

Informa Healthcare

Access to resources Recommend Favorite

Anti-vascular endothelial growth factor antibody bevacizumab reduced the risk of anemia associated with chemotherapy–A meta-analysis

By Sher Amna   Wu Shenhong  

Acta Oncologica, Vol. 50, Iss. 7, 2011-10 ,pp. : 997-1005

Informa Healthcare

Access to resources Recommend Favorite

Mechanism of action of anti-HER2 monoclonal antibodies

By Baselga J.   Albanell J.  

Annals of Oncology, Vol. 12, Iss. 12, 2001-12 ,pp. : 35-41

Springer Publishing Company

Access to resources Recommend Favorite

Bispecific antiCD3 x antiHER2 antibody mediates T cell cytolytic activity to HER2positive colorectal cancer in vitro and in vivo

By  

International Journal of Oncology, Vol. 45, Iss. 6, 2014-01 ,pp. : 2446-2454

Spandidos Publications

Access to resources Recommend Favorite